Pair Name | Rhein, Doxorubicin | ||
Phytochemical Name | Rhein (PubChem CID: 10168 ) | ||
Anticancer drug Name | Doxorubicin (PubChem CID: 31703 ) | ||
Structure of Phytochemical |
Download
2D
MOL
3D
MOL
|
||
Structure of Anticancer Drug |
Download
2D
MOL
3D
MOL
|
Pair Name | Rhein, Doxorubicin | |||
Disease Info | [ICD-11: 2C12] | Hepatocellular carcinoma | Investigative | |
Gene Regulation | Up-regulation | Activity | CASP3 | hsa836 |
In Vitro Model | SMMC-7721 | Human papillomavirus-related cervical adenocarcinoma | Homo sapiens (Human) | CVCL_0534 |
Hep-G2 | Hepatoblastoma | Homo sapiens (Human) | CVCL_0027 | |
Result | Our data indicate that a decline in mitochondrial energy metabolism was responsible for the synergistic antitumor effects of rhein and DOX in hepatocellular carcinoma cells. Reduction of ΔΨm and opening of mPTP inhibited the exchange of ATP/adenosine diphosphate between mitochondrial matrix and cytoplasm is the important mechanism. |
No. | Title | Href |
---|---|---|
1 | Synergistic antitumor effects of rhein and doxorubicin in hepatocellular carcinoma cells. J Cell Biochem. 2020 Oct;121(10):4009-4021. doi: 10.1002/jcb.27514. | Click |